Valuation: PHARMING GROUP

Market Cap 891M 808M 747M 674M 1.27B 84.03B 1.31B 8.97B 3.56B 44.89B 3.34B 3.27B 142B P/E 2026 *
41x
P/E 2027 * 33.4x
Enterprise Value 836M 758M 701M 633M 1.19B 78.87B 1.23B 8.42B 3.34B 42.13B 3.14B 3.07B 134B EV / Sales 2026 *
2.16x
EV / Sales 2027 * 1.84x
Free-Float
98.98%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 58 29/09/2026
Chief Executive Officer - 29/09/2026
Chief Tech/Sci/R&D Officer 54 01/06/2021
Director TitleAgeSince
Director/Board Member 71 11/12/2020
Director/Board Member 62 11/12/2020
Director/Board Member 60 19/05/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.82%+3.22%+42.65%+147.55% 1,286B
-0.22%+1.36%+43.27%+90.50% 688B
+0.94%+1.81%+27.61%+115.95% 521B
+1.22%+1.94%+42.37%+72.64% 386B
-0.44%-0.71%+59.06%+44.82% 364B
-0.02%+1.84%+28.49%+63.31% 302B
+0.58%+0.18%+3.68%+38.62% 287B
+0.82%+1.19%+37.77%+75.00% 252B
+1.07%+0.59%+37.26%+128.56% 208B
Average +0.52%+2.08%+35.80%+86.33% 477B
Weighted average by Cap. +0.50%+3.26%+38.14%+100.76%

Financials

2026 *2027 *
Net sales 387M 351M 325M 293M 552M 36.52B 571M 3.9B 1.55B 19.51B 1.45B 1.42B 61.93B 422M 382M 354M 319M 601M 39.79B 623M 4.25B 1.68B 21.26B 1.58B 1.55B 67.47B
Net income 26.77M 24.26M 22.44M 20.25M 38.15M 2.52B 39.5M 270M 107M 1.35B 100M 98.33M 4.28B 28.8M 26.1M 24.14M 21.78M 41.05M 2.72B 42.49M 290M 115M 1.45B 108M 106M 4.6B
Net Debt -54.72M -49.58M -45.86M -41.38M -77.98M -5.16B -80.73M -551M -218M -2.76B -205M -201M -8.75B -115M -104M -96.5M -87.07M -164M -10.86B -170M -1.16B -460M -5.8B -432M -423M -18.41B
Logo PHARMING GROUP
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The group is developing and commercializing a portfolio of innovative medicines, including small molecules and biologics.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - PHARMING GROUP